


Rolling NDA and BLA Submissions: Accelerate Your Review Timeline Blog Post
We look at the growing regulatory trend of rolling NDA and BLA submissions to help accelerate FDA review, including benefits, challenges and risks.

Industrializing QSP: Using Generative AI to accelerate the Model Life Cycle Blog Post
You may also like Fact sheetCertara.AI Fact sheet Fact sheetQSP Fact Sheet: Pioneering the Field of Quantitative Systems Pharmacology